BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16491897)

  • 1. [A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].
    Ichikawa M; Oue M; Okamoto A; Morishita H; Minatoya K; Ogino H; Miyata S; Imanaka H
    Masui; 2006 Feb; 55(2):188-92. PubMed ID: 16491897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR; Pietrangeli CE; Hursting MJ
    Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia in two patients undergoing abdominal aortic aneurysm surgery.
    Sugimoto T; Matsuo T; Wanaka K
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):110-4. PubMed ID: 19211578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
    Levine RL; Hursting MJ; McCollum D
    Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM; McCollum DA; Hursting MJ
    J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
    Yarbrough PM; Varedi A; Walker A; Rondina MT
    Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
    Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
    Hursting MJ; Verme-Gibboney CN
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban anticoagulation in critically ill patients.
    Beiderlinden M; Treschan TA; Görlinger K; Peters J
    Ann Pharmacother; 2007 May; 41(5):749-54. PubMed ID: 17440009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia.
    Reichert MG; MacGregor DA; Kincaid EH; Dolinski SY
    Ann Pharmacother; 2003 May; 37(5):652-4. PubMed ID: 12708939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
    Matthai WH; Hursting MJ; Lewis BE; Kelton JG
    Thromb Res; 2005; 116(2):121-6. PubMed ID: 15907526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia.
    Hallman SE; Hebbar L; Robison J; Uber WE
    Anesth Analg; 2005 Apr; 100(4):946-948. PubMed ID: 15781503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
    Vo QA; Lin JK; Tong LM
    Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
    Murray PT; Hursting MJ
    Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.